Shares of Celestica Inc (NYSE:CLS) (TSE:CLS) have received a consensus recommendation of “Hold” from the eleven research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation and nine have assigned a hold recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $9.00.
Several research firms have commented on CLS. Zacks Investment Research raised shares of Celestica from a “hold” rating to a “buy” rating and set a $9.75 price target for the company in a research report on Monday, April 15th. Royal Bank of Canada decreased their price target on shares of Celestica from $10.00 to $9.00 and set a “sector perform” rating for the company in a research report on Friday, April 26th. Canaccord Genuity lowered shares of Celestica from a “buy” rating to a “hold” rating in a research report on Friday, April 26th. Beacon Securities lowered shares of Celestica from a “buy” rating to a “hold” rating and decreased their price target for the company from $10.50 to $9.00 in a research report on Friday, April 26th. Finally, TD Securities decreased their price objective on shares of Celestica from $12.00 to $10.00 and set a “hold” rating for the company in a research report on Friday, February 1st.
Several institutional investors have recently made changes to their positions in CLS. Beutel Goodman & Co Ltd. purchased a new position in shares of Celestica in the 1st quarter valued at approximately $56,000. SEI Investments Co purchased a new position in shares of Celestica in the 1st quarter valued at approximately $63,000. Squarepoint Ops LLC purchased a new position in Celestica during the 4th quarter worth approximately $91,000. Citigroup Inc. raised its position in Celestica by 10,347.4% during the 4th quarter. Citigroup Inc. now owns 12,119 shares of the technology company’s stock worth $106,000 after buying an additional 12,003 shares during the last quarter. Finally, Gluskin Sheff & Assoc Inc. raised its position in Celestica by 100.2% during the 4th quarter. Gluskin Sheff & Assoc Inc. now owns 22,700 shares of the technology company’s stock worth $199,000 after buying an additional 11,360 shares during the last quarter. 64.53% of the stock is owned by hedge funds and other institutional investors.
Shares of CLS stock traded up $0.04 during mid-day trading on Thursday, hitting $6.46. 269,416 shares of the stock traded hands, compared to its average volume of 433,299. The firm has a market cap of $907.55 million, a price-to-earnings ratio of 9.23 and a beta of 0.73. Celestica has a 52-week low of $6.48 and a 52-week high of $12.59. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.08 and a current ratio of 1.81.
Celestica (NYSE:CLS) (TSE:CLS) last released its quarterly earnings results on Thursday, April 25th. The technology company reported $0.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. Celestica had a net margin of 2.67% and a return on equity of 13.21%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.24 earnings per share. As a group, equities analysts predict that Celestica will post -0.4 earnings per share for the current fiscal year.
Celestica Inc provides design, manufacturing, hardware platform, and supply chain solutions in Canada and internationally. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing, assembly and test, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Read More: Institutional Investors
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.